- Home
- LFVN vs TVGN Comparison
LFVN vs TVGN Comparison
Compare LFVN & TVGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LFVN
- TVGN
- Stock Information
- Founded
- LFVN N/A
- TVGN 2020
- Country
- LFVN United States
- TVGN United States
- Employees
- LFVN N/A
- TVGN N/A
- Industry
- LFVN Biotechnology: Pharmaceutical Preparations
- TVGN Blank Checks
- Sector
- LFVN Health Care
- TVGN Finance
- Exchange
- LFVN Nasdaq
- TVGN Nasdaq
- Market Cap
- LFVN 165.9M
- TVGN 193.1M
- IPO Year
- LFVN N/A
- TVGN N/A
- Fundamental
- Price
- LFVN $12.58
- TVGN $1.00
- Analyst Decision
- LFVN Strong Buy
- TVGN Strong Buy
- Analyst Count
- LFVN 2
- TVGN 1
- Target Price
- LFVN $30.50
- TVGN $10.00
- AVG Volume (30 Days)
- LFVN 137.9K
- TVGN 610.4K
- Earning Date
- LFVN 08-27-2025
- TVGN 08-13-2025
- Dividend Yield
- LFVN 1.43%
- TVGN N/A
- EPS Growth
- LFVN 152.87
- TVGN N/A
- EPS
- LFVN 0.70
- TVGN N/A
- Revenue
- LFVN $222,347,000.00
- TVGN N/A
- Revenue This Year
- LFVN $17.36
- TVGN N/A
- Revenue Next Year
- LFVN $9.60
- TVGN N/A
- P/E Ratio
- LFVN $17.95
- TVGN N/A
- Revenue Growth
- LFVN 8.22
- TVGN N/A
- 52 Week Low
- LFVN $7.09
- TVGN $0.26
- 52 Week High
- LFVN $27.38
- TVGN $3.09
- Technical
- Relative Strength Index (RSI)
- LFVN 45.44
- TVGN 33.32
- Support Level
- LFVN $12.03
- TVGN $1.04
- Resistance Level
- LFVN $14.91
- TVGN $1.11
- Average True Range (ATR)
- LFVN 0.75
- TVGN 0.07
- MACD
- LFVN -0.07
- TVGN -0.02
- Stochastic Oscillator
- LFVN 19.10
- TVGN 5.60
About LFVN Lifevantage Corporation (Delaware)
Lifevantage Corp is engaged in the identification, research, development, and distribution of nutraceutical dietary supplements and skincare products. It offers products such as Protandim, a scientifically-validated dietary supplement; LifeVantage TrueScience, an anti-aging skincare product; Axio energy drink mixes; and PhysIQ, a weight management system and other product Geographically, its products are sold in the regions of the United States, Japan, Hong Kong, Australia, Canada, Philippines, Mexico, Thailand, the United Kingdom, and the Netherlands.
About TVGN Tevogen Bio Holdings Inc. Common Stock
Tevogen Bio Holdings Inc a clinical-stage specialty immunotherapy company harnessing CD8+ cytotoxic T lymphocytes (CD8+ CTLs or CTLs), to develop off-the-shelf, precision T cell therapies for the treatment of infectious diseases, cancers, and neurological disorders.